Pyogenic granuloma (PG) is a benign tumor that is composed of an accumulation of inflammatory cells, such as macrophages and neutrophils. It is commonly found on the skin and mucous membranes and can range in size from a few millimeters to several centimeters. It is also referred to as a lobular capillary hemangioma or a granuloma pyogenicum. Although it is not a life-threatening condition, it can be unsightly and cause discomfort. The exact cause of PG is unknown, but it is thought to be related to a combination of factors, including trauma, hormones, and certain medications. Treatment options vary depending on the size and location of the tumor, but may include topical creams, cryotherapy, and surgical excision. In this article, we will discuss the causes, symptoms, diagnosis, and treatments of PG.
Pyogenic granuloma is a benign tumor composed of an accumulation of inflammatory cells, such as macrophages and neutrophils. It is commonly found on the skin and mucous membranes and can range in size from a few millimeters to several centimeters. It is also referred to as a lobular capillary hemangioma or a granuloma pyogenicum. PG typically presents as a red, raised, and often ulcerated nodule. It is usually painless, but can be itchy or tender. The tumor is typically found on the head, neck, and upper extremities, but can also occur on the trunk and lower extremities.
The exact cause of PG is unknown, but it is thought to be related to a combination of factors, including trauma, hormones, and certain medications. Trauma to the skin, such as a cut or scrape, can cause the skin to become inflamed, which can trigger the development of PG. Hormonal changes, such as those that occur during pregnancy, can also cause PG. This is thought to be due to the increased levels of estrogen and progesterone, which can cause the blood vessels to become more fragile and prone to injury. Certain medications, such as those used to treat acne, can also trigger the development of PG. These medications can cause inflammation and irritation of the skin, which can lead to the formation of PG.
The most common symptom of PG is a red, raised, and often ulcerated nodule. It is usually painless, but can be itchy or tender. The tumor is typically found on the head, neck, and upper extremities, but can also occur on the trunk and lower extremities.
The diagnosis of PG is typically made based on the appearance of the tumor. If the diagnosis is uncertain, a biopsy may be performed to confirm the diagnosis. During a biopsy, a sample of the tissue is taken and examined under a microscope.
Treatment options vary depending on the size and location of the tumor. Smaller tumors can often be treated with topical creams, such as corticosteroids. These creams can reduce inflammation and help to shrink the tumor. Cryotherapy, or the use of cold temperatures to destroy tissue, can also be used to treat PG. This is often used for larger tumors that are located on the face or other visible areas. In some cases, surgical excision may be necessary to remove the tumor. This is typically done under local anesthesia and the area is then closed with sutures.
Pyogenic granuloma is a benign tumor composed of an accumulation of inflammatory cells. The exact cause of PG is unknown, but it is thought to be related to a combination of factors, including trauma, hormones, and certain medications. Treatment options vary depending on the size and location of the tumor, but may include topical creams, cryotherapy, and surgical excision. It is important to seek medical attention if you notice any suspicious growths on your skin or mucous membranes.
1.
Study recommends new grading system for invasive squamous cell carcinoma of the lung
2.
Bayer is transforming pharmaceutical research into women's health
3.
Ineffective medication can remove the "worst fear" of schizophrenia.
4.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
5.
A healthier lifestyle after bowel screening shown to prevent bowel cancer
1.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
2.
Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology
3.
Everything You Need To Know About Splenic Infarction – Symptoms, Treatments, And Prevention
4.
Antibody-Drug Conjugates in Oncology: Breakthroughs, Clinical Updates, and Pipeline Innovation
5.
Understanding Leiomyoma: Causes, Symptoms, and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation